Vision Financial Markets LLC Invests $1.78 Million in UnitedHealth Group Incorporated $UNH

Vision Financial Markets LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the second quarter, Holdings Channel.com reports. The firm purchased 5,700 shares of the healthcare conglomerate’s stock, valued at approximately $1,778,000. UnitedHealth Group makes up about 1.7% of Vision Financial Markets LLC’s investment portfolio, making the stock its 14th largest position.

Other institutional investors have also recently added to or reduced their stakes in the company. Signet Investment Advisory Group Inc. increased its stake in UnitedHealth Group by 2.3% in the second quarter. Signet Investment Advisory Group Inc. now owns 7,448 shares of the healthcare conglomerate’s stock valued at $2,324,000 after purchasing an additional 165 shares during the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd raised its stake in UnitedHealth Group by 41.1% during the 2nd quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 19,733 shares of the healthcare conglomerate’s stock worth $6,156,000 after acquiring an additional 5,748 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in UnitedHealth Group by 17.4% in the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 273,118 shares of the healthcare conglomerate’s stock valued at $85,205,000 after acquiring an additional 40,500 shares in the last quarter. Advisory Alpha LLC increased its position in shares of UnitedHealth Group by 20.4% during the second quarter. Advisory Alpha LLC now owns 5,486 shares of the healthcare conglomerate’s stock worth $1,712,000 after purchasing an additional 931 shares in the last quarter. Finally, SYM FINANCIAL Corp boosted its position in shares of UnitedHealth Group by 5.0% in the 2nd quarter. SYM FINANCIAL Corp now owns 3,315 shares of the healthcare conglomerate’s stock valued at $1,034,000 after purchasing an additional 157 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on UNH. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Piper Sandler reduced their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Barclays lifted their target price on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Finally, The Goldman Sachs Group started coverage on UnitedHealth Group in a report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target for the company. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $385.13.

UnitedHealth Group Trading Up 1.0%

Shares of UNH stock opened at $365.97 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business’s fifty day moving average price is $339.58 and its 200 day moving average price is $334.29. The firm has a market capitalization of $331.45 billion, a PE ratio of 15.86, a P/E/G ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period last year, the company earned $6.80 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.